Study of cabozantinib with atezolizumab compared to sorafenib in untreated patients with advanced liver cancer (hepatocellular carcinoma)
- Substances:AtezolizumabCabozantinib+1
Belgium- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
Rare diseases
Investigational molecules
Locations
BelgiumStudy on the Effects of Mycophenolate Mofetil and Prednisolone in Patients with Chronic Virus-Negative Inflammatory Cardiomyopathy
GermanyStudy on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant
AustriaStudy on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment
BelgiumStudy on Irinotecan for Brain Metastases in Patients with HER2-Negative Breast Cancer
SpainStudy of Durvalumab and Tremelimumab for Patients with Colorectal and Endometrial Cancer
SpainStudy on Dalbavancin and Rifampicin for Treating Prosthetic Joint Infections in Patients with Hip, Knee, and Shoulder Replacements
FranceStudy of lenvatinib treatment benefits in patients with non-resectable liver cancer (hepatocellular carcinoma) who are on liver transplant waiting list after unsuccessful TACE therapy
FranceStudy on the Safety and Effectiveness of LIB-01 for Treating Erectile Dysfunction in Adult Men
Denmark
AustriaStudy on Azithromycin for Treating Chronic Sinusitis in Adults
FranceStudy on Faricimab for Patients with Neovascular Age-Related Macular Degeneration Who Have Not Received Prior Treatment
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.